CO5031290A1 - Formulacion lo - Google Patents
Formulacion loInfo
- Publication number
- CO5031290A1 CO5031290A1 CO97042583A CO97042583A CO5031290A1 CO 5031290 A1 CO5031290 A1 CO 5031290A1 CO 97042583 A CO97042583 A CO 97042583A CO 97042583 A CO97042583 A CO 97042583A CO 5031290 A1 CO5031290 A1 CO 5031290A1
- Authority
- CO
- Colombia
- Prior art keywords
- pharmaceutically acceptable
- methoxyimino
- azabicyclo
- acetonitrile
- oct
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Un medicamento que contiene [R-(Z)]-a-(metoxiimino)-a-(1-azabiciclo[2.2.2]oct-3-il) acetonitrilo, o una sal farmacéuticamente aceptable del mismo, para el tratamiento, y/o la profilaxis de la demencia en seres humanos, que está adaptado para ser aplicado a la piel.Un método para el tratamiento y/o la profilaxis de la demencia de seres humanos mediante la administración a la piel de [R-(Z)]-a-(metoxiimino)-a-(1-azabiciclo[2.2.2]oct-3-il)acetonitrilo, o una sal farmacèuticamente aceptable del mismo.Una composición farmacéutica para la administración a la piel, que comprende [R-(Z)]-a-(metoxiimino)-a-(1-azabiciclo[2.2.2]oct-3-il)acetonitrilo, o una sal farmacéuticamente aceptable del mismo, junto con vehículo adecuado farmacéuticamente aceptable.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9615628.6A GB9615628D0 (en) | 1996-07-25 | 1996-07-25 | Formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5031290A1 true CO5031290A1 (es) | 2001-04-27 |
Family
ID=10797487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO97042583A CO5031290A1 (es) | 1996-07-25 | 1997-07-25 | Formulacion lo |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0918521B1 (es) |
| JP (1) | JP2000515868A (es) |
| KR (1) | KR20000029523A (es) |
| CN (1) | CN1226163A (es) |
| AR (1) | AR007983A1 (es) |
| AT (1) | ATE224711T1 (es) |
| BR (1) | BR9710546A (es) |
| CA (1) | CA2261233A1 (es) |
| CO (1) | CO5031290A1 (es) |
| CZ (1) | CZ22799A3 (es) |
| DE (1) | DE69715878T2 (es) |
| DK (1) | DK0918521T3 (es) |
| ES (1) | ES2184121T3 (es) |
| GB (1) | GB9615628D0 (es) |
| HK (1) | HK1021314A1 (es) |
| IL (1) | IL128095A (es) |
| NO (1) | NO990283L (es) |
| NZ (1) | NZ333704A (es) |
| PL (1) | PL331283A1 (es) |
| PT (1) | PT918521E (es) |
| TR (1) | TR199900141T2 (es) |
| TW (1) | TW426514B (es) |
| WO (1) | WO1998004258A1 (es) |
| ZA (1) | ZA976592B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9815383D0 (en) * | 1998-07-15 | 1998-09-16 | Smithkline Beecham Plc | Novel method of treatment |
| US6835850B2 (en) * | 2000-09-27 | 2004-12-28 | Dsw Ip Assets B.V. | Process for the carbonylation of a conjugated diene |
| GB0428170D0 (en) * | 2004-12-23 | 2005-01-26 | Biopartners Ltd | Mono and Combination Therapy |
| SG11202005962YA (en) | 2017-12-29 | 2020-07-29 | Guangzhou Maxinovel Pharmaceuticals Co Ltd | Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and application |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0392803B1 (en) * | 1989-04-13 | 2004-06-16 | Beecham Group p.l.c. | Novel compounds |
| MX9300875A (es) * | 1992-02-20 | 1993-08-31 | Smithkline Beecham Plc | Procedimiento para la preparacion de compuestos azabiciclicos. |
| GB9409705D0 (en) * | 1994-05-14 | 1994-07-06 | Smithkline Beecham Plc | Novel compounds |
| DE19501022C1 (de) * | 1995-01-14 | 1996-06-05 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung |
-
1996
- 1996-07-25 GB GBGB9615628.6A patent/GB9615628D0/en active Pending
-
1997
- 1997-07-14 CA CA002261233A patent/CA2261233A1/en not_active Abandoned
- 1997-07-14 BR BR9710546A patent/BR9710546A/pt unknown
- 1997-07-14 IL IL12809597A patent/IL128095A/en not_active IP Right Cessation
- 1997-07-14 DE DE69715878T patent/DE69715878T2/de not_active Expired - Fee Related
- 1997-07-14 WO PCT/EP1997/003872 patent/WO1998004258A1/en not_active Application Discontinuation
- 1997-07-14 KR KR1019997000576A patent/KR20000029523A/ko not_active Application Discontinuation
- 1997-07-14 CZ CZ99227A patent/CZ22799A3/cs unknown
- 1997-07-14 ES ES97934492T patent/ES2184121T3/es not_active Expired - Lifetime
- 1997-07-14 DK DK97934492T patent/DK0918521T3/da active
- 1997-07-14 PL PL97331283A patent/PL331283A1/xx unknown
- 1997-07-14 CN CN97196687A patent/CN1226163A/zh active Pending
- 1997-07-14 TR TR1999/00141T patent/TR199900141T2/xx unknown
- 1997-07-14 EP EP97934492A patent/EP0918521B1/en not_active Expired - Lifetime
- 1997-07-14 JP JP10508451A patent/JP2000515868A/ja active Pending
- 1997-07-14 NZ NZ333704A patent/NZ333704A/en unknown
- 1997-07-14 AT AT97934492T patent/ATE224711T1/de not_active IP Right Cessation
- 1997-07-14 PT PT97934492T patent/PT918521E/pt unknown
- 1997-07-23 AR ARP970103327A patent/AR007983A1/es unknown
- 1997-07-24 TW TW086110515A patent/TW426514B/zh not_active IP Right Cessation
- 1997-07-24 ZA ZA976592A patent/ZA976592B/xx unknown
- 1997-07-25 CO CO97042583A patent/CO5031290A1/es unknown
-
1999
- 1999-01-22 NO NO990283A patent/NO990283L/no unknown
- 1999-12-01 HK HK99105593A patent/HK1021314A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TR199900141T2 (xx) | 1999-03-22 |
| GB9615628D0 (en) | 1996-09-04 |
| TW426514B (en) | 2001-03-21 |
| DE69715878T2 (de) | 2003-05-22 |
| CA2261233A1 (en) | 1998-02-05 |
| PT918521E (pt) | 2003-02-28 |
| ZA976592B (en) | 1999-03-04 |
| WO1998004258A1 (en) | 1998-02-05 |
| BR9710546A (pt) | 1999-08-17 |
| NZ333704A (en) | 2000-06-23 |
| ATE224711T1 (de) | 2002-10-15 |
| HK1021314A1 (en) | 2000-06-09 |
| AU721101B2 (en) | 2000-06-22 |
| IL128095A0 (en) | 1999-11-30 |
| KR20000029523A (ko) | 2000-05-25 |
| NO990283L (no) | 1999-03-19 |
| CZ22799A3 (cs) | 1999-06-16 |
| DE69715878D1 (de) | 2002-10-31 |
| DK0918521T3 (da) | 2003-02-03 |
| CN1226163A (zh) | 1999-08-18 |
| NO990283D0 (no) | 1999-01-22 |
| EP0918521B1 (en) | 2002-09-25 |
| PL331283A1 (en) | 1999-07-05 |
| EP0918521A1 (en) | 1999-06-02 |
| JP2000515868A (ja) | 2000-11-28 |
| AU3768497A (en) | 1998-02-20 |
| IL128095A (en) | 2002-07-25 |
| AR007983A1 (es) | 1999-11-24 |
| ES2184121T3 (es) | 2003-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2074124T5 (es) | Composicion en forma de una espuma que contiene acido 5-aminosalicilico para administracion intra-rectal. | |
| HK1003978A1 (en) | Composition for the treatment of schizophrenia | |
| EP0497258A3 (en) | Use of adenosine antagonists in the prevention and treatment of pancreatitis and ulcer | |
| IT1170214B (it) | Composizione farmaceutica per la cura delle arteriopatie periferiche | |
| DE69200711D1 (de) | Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung. | |
| CO5031291A1 (es) | Composicion farmaceutica | |
| EP1304108A3 (en) | Anti-arrhythmic composition and methods of treatment | |
| AU8687391A (en) | Lithium treatment | |
| DE3873603D1 (de) | Zusammensetzung gegen coccidiosis. | |
| CO5031290A1 (es) | Formulacion lo | |
| EP0799618A3 (en) | Use of alpha1-adrenoreceptor antagonists in the manufacture of a medicament for the prevention and teatment of cancer | |
| AU4040195A (en) | Topical composition containing penciclovir | |
| AR027037A1 (es) | Compusto y metodo para el tratamiento del dolor | |
| AU3429393A (en) | Pharmaceutical pentapeptide compositions and methods of use thereof | |
| AR010343A1 (es) | Uso de 17 beta-dihidroequilenina o una sal farmaceuticamente aceptable del ester de 17 beta-dihidroequilenina-3-sulfato para la manufactura de unmedicamento como antioxidante y composicion farmaceutica. | |
| OA09771A (en) | Asphodelus composition for increasing white blood cell count. | |
| IT1246195B (it) | Composizioni farmaceutiche contenenti antibiotici aminoglicosidici atte alla somministrazione topica | |
| ES2062752T3 (es) | Preparado de una sal de oxipurinol en forma oral para el tratamiento de hiperuricemia. | |
| IT1264428B1 (it) | Composizioni farmaceutiche per il trattamento della psoriasi | |
| IT1251993B (it) | Composizioni farmaceutiche ad uso orale,a base di esteri di gangliosidi,per il trattamento di neuropatie del sistema nervoso periferico | |
| AR006437A1 (es) | Uso de monohidrocloruro de n-(endo-9-metil-9-azabiciclo [3.3.1]non-3-il)-1- metilimidazol-3-carboxamida, para la fabricacion de un medicamento para eltratamiento o la profilaxis de diarrea y una composicion farmaceutica que lo contiene | |
| TW333453B (en) | Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases | |
| CO4700451A1 (es) | Dimaleato de n,n-dietil-8, 8-dipropil-2-azaspiro[4.5] decano-2-propanamina | |
| IT1270958B (it) | Composizioni farmaceutiche a base di nimesulide, somministrabili per via orale, non gastrolesive e/o a rilascio controllato | |
| IT1232963B (it) | Composizioni farmaceutiche topiche contenenti antiistaminici h2 |